Powerful AI, combined with comprehensive data,
simplifies the discovery and synthesis of clinical trial
information to accelerate innovation in the medical field
HENDERSON, Nev., April 15,
2024 /PRNewswire/ -- Research
Solutions (NASDAQ: RSSS), a trusted partner providing
cloud-based workflow solutions to accelerate research for
R&D-driven organizations, today launches their new
Clinical Trial Landscape software solution, making clinical trial
information more accessible, insightful, and actionable. Clinical
trials are essential research studies that assess the efficacy and
safety of medical interventions, informing regulatory decisions,
guiding healthcare practices, and advancing medical knowledge and
patient care.
This addition to Research Solutions' product family uses AI to
transform how medical science liaisons, medical affairs
specialists, and clinical development teams explore, review, and
synthesize multiple clinical trials and relevant data to map the
overall landscape quickly.
Designed with precision, this new tool addresses the critical
need for comprehensive, bias-free access to global clinical trial
information and a streamlined process for identifying and
summarizing available insights. Offering features such as adverse
event filtering, detailed analytics, and guided search and
refinement, the Clinical Trial Landscape solution ensures users can
efficiently identify the most experienced Principal Investigators
(PIs) and relevant publications for their specific research
areas.
Key benefits include:
- Enhanced PI Discovery: Utilizing sophisticated
analytics, users can generate heatmaps of the most frequent PIs in
their disease space, seamlessly connecting with the top experts and
their publications.
- Flexible Research Experience: With many field and filter
options to tailor the search strategy (including, but not limited
to, dates, sponsor type, and associated publications), researchers
are then equipped to tailor their investigation process, focusing
on the information that matters most.
- Streamlined Access to Global Data Sources: Aggregating
content from trusted registries and databases, such as
ClinicalTrials.gov and PubMed, ensures users have comprehensive
access to current and relevant data without the bias of data
curation.
"With our advanced AI and comprehensive data, we're able to help
teams and individuals navigate the vast landscape of clinical
research, efficiently and effectively," said Eléonore
Dixon-Roche, Product Manager at Research Solutions.
The launch of the Clinical Trial Landscape solution represents
another significant step forward in Research Solutions' commitment
to fostering progress in the scientific community. It is expected
to solidify further their position as a leader in scientific data
integration, as well as drive growth by attracting new users and
strengthening relationships with existing customers.
With this software solution launch, their acquisitions of
ResoluteAI and scite, and the recent introduction of their
Technology Landscape solution, Research Solutions is building
a robust ecosystem designed to fuel innovation and deliver
strategic advantages to customers.
To learn more about the Clinical Trial Landscape, and to see
firsthand how this solution advances innovations in the healthcare
and medical sectors, join their upcoming webinar:
https://bit.ly/3PE0ETB.
About Research Solutions
Research Solutions, Inc. (NASDAQ: RSSS) provides cloud-based
technologies to streamline the process of accessing, managing, and
creating intellectual property. Since its founding, the company has
been a pioneer in developing solutions to serve researchers. Today,
more than 70 percent of the top pharmaceutical companies,
prestigious universities, and emerging businesses rely on our
family of products, powered by AI and NLP technologies, to support
the innovation process from end to end with the most comprehensive
information and knowledge tools on the market. For more information
and details, please visit www.researchsolutions.com.
Important Cautions Regarding Forward-Looking
Statements
Certain statements in this press release may contain
"forward-looking statements" regarding future events and our future
results. All statements other than statements of historical facts
are statements that could be deemed to be forward-looking
statements. These statements are based on current expectations,
estimates, forecasts, and projections about the markets in which we
operate and the beliefs and assumptions of our management. Words
such as "expects," "anticipates," "targets," "goals," "projects",
"intends," "plans," "believes," "seeks," "estimates," "endeavors,"
"strives," "may," or variations of such words, and similar
expressions are intended to identify such forward-looking
statements. Readers are cautioned that these forward-looking
statements are subject to a number of risks, uncertainties and
assumptions that are difficult to predict, estimate or verify.
Therefore, actual results may differ materially and adversely from
those expressed in any forward-looking statements. Such risks and
uncertainties include those factors described in the Company's most
recent annual report on Form 10-K, as such may be amended or
supplemented by subsequent quarterly reports on Form 10-Q, or other
reports filed with the Securities and Exchange Commission. Examples
of forward-looking statements in this release include statements
regarding additional customers, potential acquisitions and the
Company's prospects for growth, profitability, and cash flow.
Readers are cautioned not to place undue reliance on these
forward-looking statements. The forward-looking statements are made
only as of the date hereof, and the Company undertakes no
obligation to publicly release the result of any revisions to these
forward-looking statements. For more information, please refer to
the Company's filings with the Securities and Exchange
Commission.
For more information about Research Solutions,
visit: www.researchsolutions.com | LinkedIn | Facebook | Twitter
SOURCE Research Solutions, Inc.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/research-solutions-unveils-ai-platform-for-automated-clinical-trial-landscape-reports-302116712.html
SOURCE Research Solutions, Inc.